9,409 followers
an open-label, phase 2 trial investigating neoadjuvant apatinib combined with oxaliplatin and capecitabine in patients with locally advanced adenocarcinoma of stomach or gastroesophageal junction. Read it here: https://t.co/NukvgkGlQ6 https://t.co/i73kQEH